Gene · 8456
Papers1,428
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,428
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression. | Cancer Immunol Immunother | 2024 | 38175202 | PubTator, text mining | PubMed |
| Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. | Nat Commun | 2024 | 38167301 | PubTator, text mining | PubMed |
| Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2. | EJNMMI Radiopharm Chem | 2024 | 38165538 | PubTator, text mining | PubMed |
| Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib. | Biochem Pharmacol | 2024 | 38036189 | PubTator, text mining | PubMed |
| Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF. | Nucleic Acids Res | 2024 | 37993417 | PubTator, text mining | PubMed |
| Targeted m6A demethylation of ITGA6 mRNA by a multisite dCasRx-m6A editor inhibits bladder cancer development. | J Adv Res | 2024 | 37003532 | PubTator, text mining | PubMed |
| HOXA3 functions as the on-off switch to regulate the development of hESC-derived third pharyngeal pouch endoderm through EPHB2-mediated Wnt pathway. | Front Immunol | 2023 | 38259452 | PubTator, text mining | PubMed |
| Thymic Carcinoma: Unraveling Neuroendocrine Differentiation and Epithelial Cell Identity Loss. | Cancers (Basel) | 2023 | 38201543 | PubTator, text mining | PubMed |
Local Magnetic Hyperthermia and Systemic Gemcitabine/Paclitaxel Chemotherapy Triggers Neo-Angiogenesis in Orthotopic Pancreatic Tumors without Involvement of Auto/Paracrine Tumor Cell VEGF Signaling and Hypoxia. | Cancers (Basel) | 2023 | 38201461 | PubTator, text mining | PubMed |
| Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α. | Oncol Res | 2023 | 38188684 | PubTator, text mining | PubMed |
| Brain trust. | Compr Psychoneuroendocrinol | 2023 | 38108028 | PubTator, text mining | PubMed |
| The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells. | Front Oncol | 2023 | 38074643 | PubTator, text mining | PubMed |
| Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery. | Biomater Res | 2023 | 38031117 | PubTator, text mining | PubMed |
| Improving thymus implantation for congenital athymia with interleukin-7. | Clin Transl Immunology | 2023 | 38020730 | PubTator, text mining | PubMed |
| A missense mutation in Lama3 causes androgen alopecia. | Sci Rep | 2023 | 38012251 | PubTator, text mining | PubMed |
| OVOL2 sustains postnatal thymic epithelial cell identity. | Nat Commun | 2023 | 38012144 | PubTator, text mining | PubMed |
| Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer. | Antioxidants (Basel) | 2023 | 38001858 | PubTator, text mining | PubMed |
| Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy. | Cell Death Dis | 2023 | 37996408 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Analysis for Thymic Epithelial Cells of Aged Mice and Humans. | Immune Netw | 2023 | 37970235 | PubTator, text mining | PubMed |
| Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. | J Med Chem | 2023 | 37967851 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8456/papers?page=4